GoodRx Holdings Inc. (GDRX) PT Lowered to $44 at Cowen

Go back to GoodRx Holdings Inc. (GDRX) PT Lowered to $44 at Cowen

GoodRx Holdings Inc. (GDRX) PT Lowered to $50 at RBC Capital

May 14, 2021 6:29 AM EDT

RBC Capital analyst Mark Mahaney lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $50.00 (from $56.00) while maintaining a Outperform rating.... More

GoodRx Holdings Inc. (GDRX) PT Lowered to $37 at BofA Securities

May 14, 2021 5:34 AM EDT

BofA Securities lowered its price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $37.00 (from $53.00) while maintaining a Neutral rating.... More

GoodRx Holdings Inc. (GDRX) PT Lowered to $33 at Barclays

May 14, 2021 5:30 AM EDT

Barclays analyst Ross Sandler lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $33.00 (from $43.00) while maintaining a Equalweight rating.... More

GoodRx Holdings Inc. (GDRX) PT Lowered to $53 at Citi

May 14, 2021 5:28 AM EDT

Citi analyst Nicholas Jones lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $53.00 (from $70.00) while maintaining a Buy rating.... More

GoodRx Holdings, Inc. (GDRX) Reports In-Line Q1 EPS, Offers Guidance

May 13, 2021 4:22 PM EDT

GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q1 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $160.4 million versus the consensus estimate of $160.58 million.

GUIDANCE:

GoodRx Holdings, Inc. sees Q2 2021 revenue of $172-176 million, versus... More